Novo Nordisk investment to create hundreds of jobs
Novo Nordisk has revealed plans to invest 2.1 billion kroner in a new insulin filling facility in a move that is expected to generate 450 new jobs.
The filling facility will consist of 10,300 square metres and will be located just north of Copenhagen in Hillerød, where the company already employs some 1,900 people.
“The investment in Hillerød underscores our long-term ambition to create and maintain jobs in Denmark. This year alone we have created 1,000 new jobs in Denmark, of which 500 are in production, primarily in Kalundborg and Hillerød,” said Henrik Wulff, the executive vice president and head of Novo Nordisk’s product supply division.
Year for investment
The new facility in Hillerød will be charged with filling the pharmaceutical giant’s current and future insulin products.